sur NANOBIOTIX (EPA:NANO)
Nanobiotix Announces Voting Rights and Share Capital Details
On September 12, 2025, Nanobiotix, a biotechnology firm listed on both Euronext Paris and Nasdaq, disclosed its voting rights and share capital details. As of August 31, 2025, the company reported 48,236,771 outstanding shares. The total theoretical voting rights amounted to 50,337,954, while the exercisable voting rights were 50,315,836.
This information follows French financial regulations, ensuring transparency within the market. Nanobiotix, operating since 2003 and a pioneer in physics-based medical treatments, maintains a solid presence in both European and American markets.
The company's philosophy focuses on expanding possibilities for human life, upheld by its significant patent portfolio and technological platforms in oncology and neuroscience.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NANOBIOTIX